Back to search

Belgium· BE-AMP-SAM032006-00

Methergin 0.2 mg/ml

A methylergometrine product containing methylergometrine maleate, registered in Belgium by Essential Pharma. The same ATC class is registered in 11 of our 19 countries.

ATC G02AB01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMethergin 0.2 mg/mlATCG02AB01REGISTER NO.BE-AMP-SAM032006-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Methylergometrine is registered in 11 of 19 countries.

Countries holding a registration under ATC G02AB01 (methylergometrine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Methylergometrine · ATC G02AB01

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylergometrine costs, country by country.

Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Methylergometrine · price per daily dose (0.2 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Methylergometrine Maleate
Manufacturer
Essential Pharma
Country
Belgium (BE)
ATC code
G02AB01
ATC class
Methylergometrine
Defined daily dose
0.2 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0057158
    EUR 7.59
  • be_apb
    0711747

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

138 interactions on record for methylergometrine.

Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methylergometrine · interactions on record

138 records

  • 43 severe
  • 90 moderate
  • 5 info

Most severe, free to view

  • EpinephrineA01AD01severe
  • IsomethepteneA03AX10severe
  • LorcaserinA08AA11severe
  • PhenylpropanolaminA08AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylergometrine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylergometrine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Bulgaria · Methergin, Метергин
  • Germany · Methergin, Methergin®
  • Denmark · Methergin
  • Spain · Methergin, Methergín
  • France · Methergin
  • Greece · Demergin
  • Iceland · Methergin
  • Italy · Methergin
  • Luxembourg · Methergin
  • Netherlands · Methergin
  • Sweden · Methergin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de690900-c97d-4f0b-b7d6-6adc55213a60
GET /v1/drugs/de690900-c97d-4f0b-b7d6-6adc55213a60?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Methergin 0.2 mg/ml",
  "name_fr": "Methergin 0.2 mg/ml",
  "name_nl": "Methergin 0.2 mg/ml",
  "amp_code": "SAM032006-00",
  "strengths": [
    "0.2000",
    "0.2000",
    "7.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Methylergometrine Maleate",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Methylergometrine",
  "authorisation_numbers": [
    "BE032006"
  ]
}

See everything about methylergometrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.